By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mirna Therapeutics, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-901-0900 Fax: 512-681-5201


Company News
Mirna Announces The Publication Of New Data Supporting Potential Immune-Related Mechanism For Anti-Cancer Activity Of MRX34 11/23/2015 11:23:57 AM
Mirna Reports Third Quarter Financial Results And Recent Highlights 11/13/2015 11:47:58 AM
Mirna Announces Presentation Of Interim Data From Ongoing Phase I Clinical Trial Of MRX34, First-In-Class microRNA-34 mimic, In Patients With Advanced Solid Tumors 11/9/2015 2:05:23 PM
Mirna Appoints Dr. Miguel Barbosa As Executive Vice President And Chief Scientific Officer 10/27/2015 11:11:17 AM
Mirna Announces Closing Of Initial Public Offering And Concurrent Private Placement With CPRIT 10/6/2015 12:18:45 PM
Mirna Announces Pricing Of Its Initial Public Offering 10/1/2015 12:46:18 PM
Mirna Sets Terms For $65 Million IPO 9/18/2015 1:03:47 PM
Micro Cancer Fighter Mirna Files for $81 Million IPO 8/25/2015 6:32:30 AM
Mirna Therapeutics Rakes in $41.8 Million in Series D As Lonestar Bio Booms 4/30/2015 6:55:12 AM
Marina Biotech, Inc. (MRNA) Reports That Partner Mirna Therapeutics, Inc. Presented Interim Phase 1 Data On Its First-in-Class microRNA-34 Mimic 11/20/2014 11:41:30 AM